Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Biochemistry 56 , 986996 (2017)
Three key findings result from our study: (1) pwIIH treated with GLP-1-RAs lose significantly more weight than pwIIH electing for UCWM only, (2) treatment with GLP-1-RAs is associated with favorable headache outcomes, and (3) treatment with GLP-1-RAs is not associated with any severe adverse events in IIH, and thus presents a safe treatment option for weight management in pwIIH
Genes Dev
Among the most discussed is L-carnitine
Vaccine 2005, 23(12):1457-1463
US$ 23.21
US$ 21.67
US$ 22.40
US$ 28.83
